COMPANY PROFILE

Kalderos

Explore full profile

Goes after the areas of conflict between players in the US healthcare system

Chicago, United StatesFounded 2016Health Tech & Medtech

Valuation $100–250M Last recorded · 2022

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Kalderos

Kalderos operates in the healthcare technology sector, providing a platform that optimizes drug discount management and compliance. The company serves healthcare providers and pharmaceutical manufacturers, ensuring accurate discount claims and preventing duplicate discounts. Kalderos leverages advanced data analytics and machine learning to streamline the complex process of drug discount management, making it more efficient and transparent. The business model is based on a subscription service, where clients pay for access to the platform and its features. Revenue is generated through these subscription fees, as well as through additional services such as consulting and custom analytics. Kalderos operates primarily in the United States, targeting large healthcare systems and pharmaceutical companies. The platform's key features include real-time data validation, comprehensive reporting tools, and automated compliance checks, which help clients save time and reduce financial risks associated with drug discount programs.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2016
Headquarters: Chicago, United States
Employees: 78
Open positions: None listed
Dealroom signal: 60.0/100
Industry: Health
Sub-industry: Health Platform
Sector: Health Tech & Medtech, Hard Tech
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITIONOther financing	Jun 2026	$0	—	Model N	↗
LATE VCOther financing	Sep 2022	$15M	$140M	Undisclosed	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Kalderos website traffic

Latest recorded traffic for Kalderos is 5.6K monthly website visits, up 5.7% over the last three months. Kalderos's team declined 35.5% over the past year.

Latest monthly visits5.6K 3-month web change+5.7% 1-year team growth-35.5%

Monthly website visitsJun 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
PHPhysikitEnabling at-home testing as a service for healthcare providers	Berlin, Germany	Operational	11	$187K	$748K
ANAntegenesGenetic tests for personalized cancer risk prevention	Tartu, Estonia	Operational
PHPhlecsLeading phototherapy B2B platform providing non-invasive, UV-free and drug-free treatment for skin diseases	Eindhoven, Netherlands	Operational
ACAccexibleDeveloping a speech analysis platform based on AI models to early detect diseases as dementia, Parkinson, and coronary disease	Bilbao, Spain	Operational
ZGZTM Bad Kissingen GmbHDevelops and distributes products and services for telemedicine and technical assistance systems	Bad Kissingen, Germany	Operational
MLMypatientspace LimitedThe connected patient - digitize your patient journey and enable remote patient management at scale	Ireland	Operational
ZTZETA TECHNOLOGIESZeta is committed to help people suffering from tinnitus. We develop diagnostic and therapeutic tools to provide relief to people suffering from this condition	Cleveland, United States	Operational
ANAntleron NVBioprocess solutions for advanced personalized therapies	Leuven, Belgium	Operational